Public health impact of nirsevimab against acute lower respiratory infections associated with respiratory syncytial virus among Chinese infants: a modelling study

Public health impact of nirsevimab against acute lower respiratory infections associated with respiratory syncytial virus among Chinese infants: a modelling study

Background Respiratory syncytial virus (RSV) causes substantial acute lower respiratory infections (ALRI), particularly during infants’ first RSV season. This study evaluated the impact of a new long-acting monoclonal antibody, nirsevimab, on Chinese infants.Research design and methods A monthly dec...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaozhen Lai, Yidi Ma, Weishun Zou, Samira Soudani, Hai Fang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Expert Review of Vaccines
Subjects:
Acute lower respiratory infections
infant health
monoclonal antibody
public health impact
respiratory syncytial virus
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2025.2526601
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items